1 | BORTEZOMIB (D03150) | 2件: Bortezomib Bortezomib, Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
|
2 | Bortezomib (Velcade®) (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 66 66 💬
|
3 | Bortezomib Accord (D03150) | 2件: Bortezomib Bortezomib, Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
4 | Bortezomib D-mannitol (D03150) | 3件: Bortezomib Bortezomib, Bortezomib D-mannitol, Mannitol | 2件: Mannitol
Mannitol
,
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
5 | Bortezomib Injection (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 64 64 💬
|
6 | Bortezomib/dexamethasone (D03150) | 2件: Bortezomib Bortezomib, Dexamethasone | 2件: Dexamethasone
Dexamethasone
,
Bortezomib
(D03150) 💬
| 2件: NR3C1 NR3C1, PSMB5 💬
| 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 283 283 💬
|
7 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (D03150) | 2件: Bortezomib Bortezomib, Dexamethasone | 2件: Dexamethasone
Dexamethasone
,
Bortezomib
(D03150) 💬
| 2件: NR3C1 NR3C1, PSMB5 💬
| 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
8 | Combination of a single dose anti-CD20 antibody and bortezomib (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬
| 1件: PSMB5 PSMB5 💬
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 61 61 💬
|
9 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen (D03150) | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
(D03150),
Cyclophosphamide
💬
| 2件: NR3C1 NR3C1, PSMB5 💬
| 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
10 | Cyclophosphamide, Bortezomib, dexamethasone (D03150) | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
(D03150),
Cyclophosphamide
💬
| 2件: NR3C1 NR3C1, PSMB5 💬
| 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
11 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab (D03150) | 4件: Bortezomib Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone | 5件: Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
(D03150),
Cyclophosphamide
,
Daratumumab
💬
| 3件: CD38 CD38, NR3C1, PSMB5 💬
| 16件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|
12 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) (D03150) | 3件: Bortezomib Bortezomib, Cyclophosphamide, Dexamethasone | 4件: Cyclophosphamide
Cyclophosphamide
,
Dexamethasone
,
Bortezomib
(D03150),
Cyclophosphamide
💬
| 2件: NR3C1 NR3C1, PSMB5 💬
| 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 1件: 28 28 💬
|